M. Samama

704 total citations
25 papers, 509 citations indexed

About

M. Samama is a scholar working on Cardiology and Cardiovascular Medicine, Radiology, Nuclear Medicine and Imaging and Surgery. According to data from OpenAlex, M. Samama has authored 25 papers receiving a total of 509 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Cardiology and Cardiovascular Medicine, 5 papers in Radiology, Nuclear Medicine and Imaging and 4 papers in Surgery. Recurrent topics in M. Samama's work include Atrial Fibrillation Management and Outcomes (5 papers), Antiplatelet Therapy and Cardiovascular Diseases (4 papers) and Blood Coagulation and Thrombosis Mechanisms (3 papers). M. Samama is often cited by papers focused on Atrial Fibrillation Management and Outcomes (5 papers), Antiplatelet Therapy and Cardiovascular Diseases (4 papers) and Blood Coagulation and Thrombosis Mechanisms (3 papers). M. Samama collaborates with scholars based in France, Germany and Denmark. M. Samama's co-authors include J. Conard, Thomas Lecompte, L. Bara, Alain Leizorovicz, Mette Lie Larsen, Ulrich Abildgaard, Frank Brosstad, Rémi Favier, Jean‐Marc Herbert and Grigoris Gerotziafas and has published in prestigious journals such as British Journal of Haematology, Thrombosis and Haemostasis and Journal of Thrombosis and Haemostasis.

In The Last Decade

M. Samama

24 papers receiving 480 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M. Samama France 12 247 191 184 131 66 25 509
H. Kessels Netherlands 8 309 1.3× 473 2.5× 229 1.2× 191 1.5× 109 1.7× 9 770
Carlos Fondevila Argentina 11 267 1.1× 144 0.8× 129 0.7× 81 0.6× 37 0.6× 18 537
Sebastián F. Ameriso United States 4 577 2.3× 201 1.1× 212 1.2× 235 1.8× 66 1.0× 4 748
Geneviève Freyburger France 12 273 1.1× 264 1.4× 252 1.4× 105 0.8× 82 1.2× 31 632
Jessica Hirsch United States 10 139 0.6× 380 2.0× 105 0.6× 197 1.5× 73 1.1× 13 676
Zihui Xiao China 10 406 1.6× 106 0.6× 217 1.2× 226 1.7× 35 0.5× 13 616
M Samama France 9 126 0.5× 253 1.3× 129 0.7× 70 0.5× 88 1.3× 51 430
Selime Ayaz Türkiye 12 269 1.1× 66 0.3× 81 0.4× 154 1.2× 66 1.0× 29 505
Joyce Low Australia 17 147 0.6× 286 1.5× 162 0.9× 185 1.4× 73 1.1× 24 641
Anirban Choudhury United Kingdom 13 425 1.7× 69 0.4× 150 0.8× 159 1.2× 136 2.1× 32 610

Countries citing papers authored by M. Samama

Since Specialization
Citations

This map shows the geographic impact of M. Samama's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Samama with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Samama more than expected).

Fields of papers citing papers by M. Samama

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Samama. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Samama. The network helps show where M. Samama may publish in the future.

Co-authorship network of co-authors of M. Samama

This figure shows the co-authorship network connecting the top 25 collaborators of M. Samama. A scholar is included among the top collaborators of M. Samama based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Samama. M. Samama is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Samama, M., et al.. (2024). Pharmacological Benefits of Cinnamaldehyde: A Comprehensive Insight. Current Bioactive Compounds. 21(7).
2.
Poller, L., Michelle Keown, Said A. Ibrahim, et al.. (2008). An international multicenter randomized study of computer-assisted oral anticoagulant dosage vs. medical staff dosage. Journal of Thrombosis and Haemostasis. 6(6). 935–943. 90 indexed citations
3.
Gerotziafas, Grigoris & M. Samama. (2005). Heterogeneity of Synthetic Factor Xa Inhibitors. Current Pharmaceutical Design. 11(30). 3855–3876. 19 indexed citations
4.
Vine, Andrew K. & M. Samama. (2002). Prothrombotic states in retinal artery and vein occlusions. 2(2). 134–142. 5 indexed citations
5.
Gilbert, Mark R., et al.. (2000). Anti-Xa Monitoring: Inter-assay Variability. Thrombosis and Haemostasis. 84(12). 1122–1123. 1 indexed citations
6.
Herbert, Jean‐Marc, A. Bernat, M. Samama, & J.P. Maffrand. (1996). The Antiaggregating and Antithrombotic Activity of Ticlopidine Is Potentiated by Aspirin in the Rat. Thrombosis and Haemostasis. 76(1). 94–98. 39 indexed citations
7.
Hadjez, Jack, S. Combe, M.H. Horellou, et al.. (1994). Heterogeneous mechanisms responsible for reduced fibrinolytic capacity in patients with a history of venous thrombosis. Fibrinolysis and Proteolysis. 8(2). 87–95. 7 indexed citations
8.
Iung, Bernard, Bertrand Cormier, E Viguier, et al.. (1993). Small abnormal echos after mitral valve replacement with bileaflet mechanical prostheses: predisposing factors and effect on thromboembolism.. PubMed. 2(3). 259–66. 22 indexed citations
12.
Lecompte, Thomas, et al.. (1989). PL2‐49, a monoclonal antibody against glycoprotein IIb which is a platelet activator. British Journal of Haematology. 71(1). 57–63. 44 indexed citations
13.
Favier, Rémi, Thomas Lecompte, Patrick Benoit, et al.. (1989). Calcium rise in human platelets elicited by anti-CD9 and -CD41 murine monoclonal antibodies. Thrombosis Research. 55(5). 591–599. 23 indexed citations
14.
Glacet–Bernard, A., G. Coscas, F. Lelong, et al.. (1989). [Erythrocyte aggregation and retinal vein occlusion. Preliminary data for a randomized study on the efficacy of anti-erythrocyte aggregation (troxerutin) in retinal vein occlusion].. PubMed. 89(12). 1393–6. 4 indexed citations
15.
Lecrubier, C, et al.. (1987). Tests d'agrégation plaquettaire dans 26 cas de thrombopénies induites par l'héparine (TIH). Problèmes méthodologiques, diagnostiques et aspects thérapeutiques.. Journal des Maladies Vasculaires. 2 indexed citations
16.
Bara, L., et al.. (1986). Comparison of antithrombotic activity of two heparin fragments PK 10169 (mol. wt. 5,000) and EMT 680 (mol. wt. 2,500) and unfractionated heparin in a rabbit experimental thrombosis model: relative importance of systemic anti-Xa and anti-IIa activities.. PubMed. 28(6). 355–8. 1 indexed citations
17.
Conard, J., Frank Brosstad, Mette Lie Larsen, M. Samama, & Ulrich Abildgaard. (1983). Molar Antithrombin Concentration in Normal Human Plasma. Pathophysiology of Haemostasis and Thrombosis. 13(6). 363–368. 59 indexed citations
18.
Tournay, D, et al.. (1982). Hypoproconvertinémie sévère et circulation extra-corporelle pour remplacement valvulaire mitral. Annales Françaises d Anesthésie et de Réanimation. 1(4). 437–439. 1 indexed citations
19.
Conard, J., et al.. (1981). Antithrombin III in patients treated with subcutaneous or intravenous heparin. Thrombosis Research. 22(4). 507–511. 29 indexed citations
20.
Samama, M., et al.. (1978). Urokinase I and II Activity. Thrombosis and Haemostasis. 40(2). 578–580. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026